Actinomycin C2 |
 |
| PRODUCT LINE | Natural Products / Antibiotics |
|
|
| PRODUCT FAMILIES | Antitumor Antibiotics |
|
|
|
| Ordering Information |
|
| Product Numbers | Format | Size | Unit Price | Quantity | | | ALX-380-082-C500 |
|
500 µg | | | | | | |
|
|
| Product Specification |
|
|
| FORMULA: | C63H88N12O16 |
|
|
| |
|
| MW: | 1269.5 |
|
|
| |
|
| MERCK INDEX: | 14: 1606 |
|
|
| |
|
| SOURCE/HOST: | Isolated from Streptomyces sp. |
|
|
| |
|
| PURITY: | ≥98% (contains traces of ethylacetate or cyclohexane) |
|
|
| |
|
| APPEARANCE: | Orange crystals. |
|
|
| |
|
| SOLUBILITY: | Soluble in methanol, acetone or chloroform. |
|
|
| |
|
| SHIPPING: | AMBIENT |
|
|
| |
|
| LONG TERM STORAGE: | +4°C |
|
|
| |
|
| HANDLING: | Keep cool and dry. |
|
|
| |
|
| HAZARD: | TOXIC. |
|
|
| |
|
| IDENTITY: | Determined by 1H-NMR: Identical to standard reference. |
|
|
|
|
| Product Description |
|
| | Product Specific Literature References | Nomenclature of the Actinomycins: S.A. Waksman, et al.; PNAS 44, 602 (1958) Abstract
Actinomycin D, C2 and VII, inhibitors of Grb2-SHC interaction produced by Streptomyces: J. Y. Nam, et al.; Bioorg. Med. Chem. Lett. 8, 2001 (1998) Abstract |
|
|
|
|
| RELATED PRODUCT GROUPS |
DNA Regulation / Transcription > Transcription Inhibitors / Related Products |
|
|
|
